dc.contributor
Institut Català de la Salut
dc.contributor
[Malhotra S, Fissolo N, Pappolla A, Río J, Vilaseca A, Miguez A, Montalban X, Comabella M] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rodríguez-Rivera C] Area of Pharmacology and Nutrition & Bromatology, Department of Basic Health Sciences, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain. [Monreal E] Department of Neurology, Hospital Universitario Ramón y Cajal, REEM, IRYCIS, Universidad de Alcalá, Madrid, Spain. [Montpeyo M, Martinez-Vicente M] Grup de Recerca de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. [Urcelay E] Laboratorio de Investigación en Genética de Enfermedades Complejas, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain. [Pérez-García MJ, Segura MF] Grup de Recerca de Càncer i Malalties Hematològiques Infantils, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
RODRIGUEZ-RIVERA, CARMEN
dc.contributor.author
Monreal, Enric
dc.contributor.author
Montpeyó Garcia-Moreno, Marta
dc.contributor.author
Urcelay, Elena
dc.contributor.author
Perez-Garcia, Maria J
dc.contributor.author
Miguez, Andrés
dc.contributor.author
Malhotra Sareen, Sunny
dc.contributor.author
Fissolo, Nicolás Miguel
dc.contributor.author
Segura, Miguel F.
dc.contributor.author
Pappolla, Agustin
dc.contributor.author
Rio, Jordi
dc.contributor.author
Vilaseca Jolonch, Andreu
dc.contributor.author
Martinez-Vicente, Marta
dc.contributor.author
Comabella Lopez, Manuel
dc.contributor.author
Montalban, Xavier
dc.date.issued
2024-04-16T11:13:34Z
dc.date.issued
2024-04-16T11:13:34Z
dc.identifier
Malhotra S, Fissolo N, Rodríguez-Rivera C, Monreal E, Montpeyo M, Urcelay E, et al. Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis. Clin Transl Med. 2024 Apr;14(4):e1654.
dc.identifier
https://hdl.handle.net/11351/11332
dc.identifier
10.1002/ctm2.1654
dc.identifier
001198705100001
dc.description.abstract
Clusterin deficiency; Teriflunomide; Multiple sclerosis
dc.description.abstract
Deficiència de clusterina; Teriflunomida; Esclerosi múltiple
dc.description.abstract
Deficiencia de clusterina; Teriflunomida; Esclerosis múltiple
dc.description.abstract
This research was conducted using Departmental funds for Medical Research.
dc.format
application/pdf
dc.relation
Clinical and Translational Medicine;14(4)
dc.relation
https://doi.org/10.1002/ctm2.1654
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Marcadors bioquímics
dc.subject
Esclerosi múltiple - Tractament
dc.subject
Medicaments immunosupressors - Efectes secundaris
dc.subject
CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Immunologic Factors::Immunosuppressive Agents
dc.subject
Other subheadings::Other subheadings::Other subheadings::/adverse effects
dc.subject
DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis
dc.subject
Other subheadings::Other subheadings::Other subheadings::/drug therapy
dc.subject
CHEMICALS AND DRUGS::Biological Factors::Biomarkers
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::factores inmunitarios::inmunosupresores
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores
dc.title
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
